// App-Quantinova.ai

P395 : PHARMACEUTICAL TARGETING OF RAS IN ACUTE MYELOID LEUKAEMIA

Researchers

Presenter

  • Daniel Coleman

Principal Investigators

  • Lara Strate

  • James Griffin

  • Terry Rabbitts

  • Peter Cockerill

  • Constanze Bonifer

Medical Centers

  • The Institute of Cancer Research, London,London,Vereinigtes Königreich

  • University of Birmingham,Birmingham,Verenigd Koninkrijk

  • University of Birmingham,Birmingham,Reino Unido

  • The Institute

  • Institute for Cancer Research, London, United Kingdom

  • The Institute of Cancer Research, London, UK

  • The Institute of Cancer Research, London,London,Vereinigtes Königreich

  • The Institute of Cancer Research, London, UK

  • University of Birmingham,Birmingham,Reino Unido

  • University of Birmingham, Birmingham, United Kingdom

  • University of Birmingham,Birmingham,Соедин

  • Haematology,University Hospitals Birmingham ,Birmingham,Royaume-uni

  • Haematology,University Hospitals Birmingham ,Birmingham,Vereinigtes Königreich

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Cluster of Differentiation 34

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved